Many leukemic and lymphoma cells express CXCR4 on their surface [3,8], and CXCR4 expression levels have been proven to be a predictor of overall survival and relapse-free survival in patients with acute myeloid leukemia (AML) [13]. Here, CXCR4 is linked to lymphoma.